Bionano interim CEO Albert Luderer buys $4,845 of common shares
BNGO•Insider purchase reported
Bionano Genomics interim Chief Executive Albert Luderer reported an indirect purchase of 4,000 common shares at $1.21.
Holdings were reported as 8,000 shares following the transaction, held in a Traditional IRA.




